EXPLOITING TUMOR-ACTIVATED TESTES PROTEINS TO ENHANCE EFFICACY OF FIRST-LINE CHEMOTHERAPEUTICS IN NSCLC

The University Of Texas Southwestern Medical Center

Investigators